1.Clinical features of children with acute disseminated encephalomyelitis and related recurrence factors.
Jin RUAN ; Min CHENG ; Xiu-Juan LI
Chinese Journal of Contemporary Pediatrics 2019;21(3):223-228
OBJECTIVE:
To study the clinical features of children with acute disseminated encephalomyelitis (ADEM) and related recurrence factors.
METHODS:
A retrospective analysis was performed for the clinical data and prognosis of 73 children with ADEM who were hospitalized from November 2011 to January 2017.
RESULTS:
Among the 73 children, 41 (56%) had a history of infection before onset and 7 (10%) had a history of vaccination. All children had the symptoms of encephalopathy, including disturbance of consciousness in 47 children (64%) and mental and behavioral disorders in 54 children (74%). Pyrexia was observed in 53 children (73%), dyskinesia in 47 children (64%), headache in 47 children (64%) and vomiting in 40 children (55%). Brain MRI was performed for 65 children and the results showed involvement of the subcortical white matter (83%, 54/65), the deep nuclei (60%, 39/65), the brain stem (58%, 38/65) and the cerebellum (42%, 27/65). Spinal cord involvement was observed in 20 children (20/43, 47%). A total of 15 children experienced recurrence during follow-up. Compared with the non-recurrence group, the recurrence group had significantly higher percentages of children with deep nucleus involvement (P<0.05), with injury in ≥3 spinal segments (P<0.01) and with a time from disease onset to gamma-globulin/hormone treatment of >2 weeks (P<0.05).
CONCLUSIONS
ADEM in children have various clinical manifestations. A small number of children may experience recurrence. Deep nucleus involvement on MRI, long spinal segmental injury (≥3 segments) and late treatment with gamma-globulin/hormone (>2 weeks) may be associated with the recurrence of ADEM.
Child
;
Encephalomyelitis, Acute Disseminated
;
Humans
;
Magnetic Resonance Imaging
;
Prognosis
;
Recurrence
;
Retrospective Studies
2.Research progress of enhancing quantitative sensitivity by using LC-MS(n) with derivatization method in bio-matrices.
Ying LI ; Li-Li XU ; Jin-Xiu RUAN ; Zhen-Qing ZHANG
Acta Pharmaceutica Sinica 2011;46(6):637-641
Liquid chromatography/mass spectrometry (LC-MS(n)) has been essential to a large number of quantitative analytical applications in drug research, and especially in the drug PK/PD research, due to its high sensitivity and high specificity. But following the appearance of drugs with high activity and low dosage and the especial structural compounds, a number of limitations of LC-MS(n) have been noted. Derivatization changes the structure of drugs and therefore changes their physical and chemical properties, resulting in high ionization efficiency, low matrix effect and low disturbance by inorganic salts and endogenous compounds in LC-MS(n). In this article, recent progress in the research of the chemical derivatization strategy with LC-MS(n) is reviewed on breakthrough of some LC-MS(n) limitations, in particular focusing on the applications involving some drugs in bio-matrices.
Animals
;
Chemistry Techniques, Analytical
;
methods
;
Chromatography, Liquid
;
methods
;
Humans
;
Mass Spectrometry
;
methods
;
Pharmaceutical Preparations
;
analysis
;
Sensitivity and Specificity
3.Determination of decapeptide LXT-101 in plasma by HPLC-MS/MS and its pharmacokinetics in Beagle dogs.
Ai-ying KONG ; Zhen-qing ZHANG ; Jian-zhong QIAO ; Fan ZHANG ; Wen-xia ZHOU ; Ke-liang LIU ; Jin-xiu RUAN
Acta Pharmaceutica Sinica 2008;43(9):946-950
This paper developed a sensitive and specific liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/MS) method for the determination of decapeptide LXT-101 in Beagle dog plasma. Plasma samples spiked with internal standard (IS) were treated with acetonitrile to precipitate the protein. Selected reaction monitoring (SRM) using the precursor --> product ion combinations of m/z 472.1-->587.9 and m/z 502.8-->633.8 were used to quantify LXT-101 and IS, respectively. The linear calibration curves were obtained in the concentration range of 0.5 - 500.0 ng x mL(-1). The limit of quantification (LOQ) was 0.5 ng x mL(-1). The inter-day and intra-day precision (RSD) across three validation run over the entire concentration range was below 10.9%, and the accuracy (RE) was within +/- 1.8%. The main pharmacokinetic parameters of LXT-101 after muscle injection of 20 microg x kg(-1) were as follows, AUC(0-t): (176.8 +/- 116.7) microg x h x L(-1), MRT(0-t): (2.52 +/- 0.53) h, T(1/2): (1.4 +/- 0.3) h; CL: (0.16 +/- 0.09) L x h(-1) x kg(-1), and Vd: (0.30 +/- 0.16) L x kg(-1), respectively. The method is proved to be specific, sensitive and suitable for the investigation of LXT-101 pharmacokinetics in Beagle dog.
Animals
;
Antineoplastic Agents
;
administration & dosage
;
blood
;
pharmacokinetics
;
Area Under Curve
;
Chromatography, High Pressure Liquid
;
Dogs
;
Gonadotropin-Releasing Hormone
;
antagonists & inhibitors
;
Injections, Intramuscular
;
Male
;
Oligopeptides
;
administration & dosage
;
blood
;
pharmacokinetics
;
Spectrometry, Mass, Electrospray Ionization
4.Effect of Danxiongfang and its components on experimental liver injury models induced by CCl4 in mice.
Xiao-Rong LI ; Li-Juan WANG ; Yu-Hang LI ; Yan-Xia XU ; Yi CHEN ; Jin-Xiu RUAN ; Ming XUE
China Journal of Chinese Materia Medica 2007;32(20):2177-2181
OBJECTIVEThe study investigates the protective effect on liver of Danxionfang and its components.
METHODMice are injected with CCl4 to establish liver injured model. ALT, AST, serum albumin, globulin in serum and SOD, MDA in liver and liver histological changes were measured to confirm the ability of protecting liver of Danxiongfang.
RESULTThe results show Danxiongfang can inhibit obviously the abnormal increase of ALT, AST in serum and MDA in liver, enhance SOD activity in liver, total protein, albumin, globulin in serum, and decrease liver pathological changes, which suggests Danxiongfang can protect injured liver induced by CCl4.
CONCLUSIONDanxiongfang showed powerful protective effect against liver damage induced by CCl4.
Alanine Transaminase ; blood ; Animals ; Aspartate Aminotransferases ; blood ; Carbon Tetrachloride ; Chemical and Drug Induced Liver Injury ; Drug Combinations ; Drugs, Chinese Herbal ; isolation & purification ; pharmacology ; Female ; Ligusticum ; chemistry ; Liver ; drug effects ; metabolism ; pathology ; Liver Diseases ; blood ; prevention & control ; Male ; Malondialdehyde ; metabolism ; Mice ; Mice, Inbred ICR ; Phytotherapy ; Plants, Medicinal ; chemistry ; Protective Agents ; isolation & purification ; pharmacology ; Salvia miltiorrhiza ; chemistry ; Superoxide Dismutase ; metabolism
5.Real-time measurement of noradrenaline release in central nervous system.
Wei HUANG ; Hong-Ping HUANG ; Yu MU ; Lei ZHANG ; Mu JIN ; Jing LV ; Jing-Li GU ; Yun XIU ; Bo ZHANG ; Ning GUO ; Tao LIU ; Lei SUN ; Mei-Ying SONG ; Claire Xi ZHANG ; Huai-Zhen RUAN ; Zhuan ZHOU
Acta Physiologica Sinica 2007;59(6):865-870
In order to investigate the central nervous mechanism and the diseases involved in catecholamine transmitter secretion, the dynamics of catecholamine release is studied in single cell, brain slice or in vivo. Noradrenaline is an important neurotransmitter and modulator in the central nervous system (CNS) and the peripheral nervous system (PNS). In the present paper, we first compared three real-time methods used to measure noradrenaline secretion in single cells (membrane capacitance, amperometry and confocal fluorescence microscopy imaging). Compared to the electrophysiological method and fluorescence microscopy, the basic usage of the carbon fiber electrode (CFE) in neuroscience research was presented as an example. Then, we presented a primary description of ion channels, including voltage-gated Na(+), K(+) and Ca(2+) channels in locus coeruleus (LC) neurons in rat brain slices. Finally, we presented example recordings of combined patch-clamp and amperometry measurements in LC neurons, indicating Ca(2+)-dependent quantal noradrenaline release following Ca(2+) influx through Ca(2+) channels.
Animals
;
Central Nervous System
;
physiology
;
Ion Channels
;
physiology
;
Norepinephrine
;
secretion
;
Patch-Clamp Techniques
;
Rats
6.Analysis on prognosis and correlative factors of acute nonlymphocytic leukemia.
Chun-Yan LIU ; Rong FU ; Wen-Hui LIU ; Yu-Qian CHENG ; Wen-Xiu SONG ; Li-Juan DU ; Er-Bao RUAN ; Li-Tong ZHANG ; Xiao-Ming WANG ; Yong LIANG ; Guo-Jin WANG ; Wen QU ; Jia SONG ; Rong-Li ZHANG ; Jing GUAN ; Li-Juan LI ; Yang SONG ; Shan GAO ; Hui LIU ; Hui-Juan JIANG ; Jun WANG ; Peng ZOU ; Zong-Hong SHAO
Journal of Experimental Hematology 2007;15(6):1300-1304
To analyze the prognosis and risk factors of acute nonlymphocytic leukemia (ANLL), 94 patients with acute nonlymphocytic leukemia were enrolled in this study, while survival rate and risk factors of prognosis were analyzed. The results indicated that the complete remission (CR) ratio was 51.1%. Overall survival and event-free survival rates of month 6, 12, 18, 24 were 68.6%, 55.8%, 53.8%, 46.4%, 21.3% and 57.9%, 38.6%, 33.3%, 31.6%, 0% respectively. The factors such as age<40 years, WBC<10.0x10(9)/L before chemotherapy, WBC in the period of bone marrow suppression<1.0x10(9)/L, chemotherapy within 1 month after occurrence of leukemia, blood transfusion before chemotherapy of APL had favourable influence on remission and survival rates of ANLL patients. CR1, the time to get CR, length of CR and relapse significantly correlated with prognosis (p<0.05). It is concluded that the individualized therapy concerning the risk factors should be applied to ANLL patients for improving the remission, survival rate and prognosis.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Cytarabine
;
administration & dosage
;
therapeutic use
;
Female
;
Harringtonines
;
administration & dosage
;
therapeutic use
;
Humans
;
Leukemia, Myeloid, Acute
;
diagnosis
;
drug therapy
;
Male
;
Middle Aged
;
Prognosis
;
Tretinoin
;
administration & dosage
;
therapeutic use
;
Young Adult
7.Prognosis and related factors of acute lymphoblastic leukemia.
Wei ZHANG ; Rong FU ; Wen-Hui LIU ; Yu-Qian CHENG ; Wen-Xiu SONG ; Li-Juan DU ; Er-Bao RUAN ; Li-Tong ZHANG ; Xiao-Ming WANG ; Yong LIANG ; Guo-Jin WANG ; Wen QU ; Jia SONG ; Rong-Li ZHANG ; Jing GUAN ; Li-Juan LI ; Peng ZOU ; Zong-Hong SHAO
Journal of Experimental Hematology 2007;15(5):1102-1106
In order to analyze the prognosis and related factors of acute lymphoblastic leukemia (ALL), 53 newly diagnosed ALL patients were enrolled in this study. The therapeutic efficacy and prognosis of 53 cases of ALL were analyzed, the remission, relapse, overall survival and event-free survival were studied, and relation between different factors and prognosis of ALL were investigated by comparison of cases in same stage. The results showed that the complete remission was achieved in 36 out of 53 patients, the total remission rate was 67.9%, the total relapse rate was 37.7%, the median relapse duration was 6 months after remission. Median overall survival (OS) and median event-free survival (EFS) time were 4 and 1 months after remission respectively, OS and EFS rate of 18 month was 35.1% and 14.2%. The patients with different gender had significantly different EFS. Age was an independent risk factor of CR rate. White blood cell count and hemoglobin level of newly diagnosed patients were significantly correlated with OS and EFS. Absolute neutrophil count (ANC) at the end of the induction chemotherapy was an independent related factor of OS, the higher ANC, the lower risk of death. The patients with or without chemotherapy related infection had different relapse rate. The patients with bleeding after chemotherapy had lower OS when compared with those without bleeding. Serum glucose level was a significant negative prognostic factor. It is concluded that there is higher relapse rate, poor prognosis in adult ALL in comparison with children. In order to decrease the relapse rate and prolong the EFS, individual therapeutical regimens and prophylaxis of complicating diseases should be applied to ALL patients.
Adolescent
;
Adult
;
Aged
;
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Child
;
Female
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local
;
prevention & control
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
diagnosis
;
therapy
;
Prognosis
;
Young Adult
8.Study on content variation of triptolide in medicinal material of Tripterygium.
Jin-Ping SI ; Wen-Hua HUANG ; Bao-Lin GUO ; Xiu-Chun RUAN ; Shi-Jie LI
China Journal of Chinese Materia Medica 2006;31(24):2026-2030
OBJECTIVETo study the content variation of triptolide in medicinal material of Tripterygium and provide theoretical basis for the hereditary improvement, the gathering and process, the quality evaluation and the provenance division in medicinal material of Tripterygium.
METHODHPLC method was used to determine the content of triptolide.
RESULTThe relations between triptolide and germplasm, growth year, gathering season were found out basically.
CONCLUSIONThe triptolide contents in xylem are affected by hereditary factors remarkably. While the triptolide contents in phloem are not affected obviously. The accumulation of triptolide needs the certain growth years. However when growth is beyond certain years, the triptolide content decreases with the disintegration of secondary metabolism in xylem. The triptolide in xylem is highest in winter and decreasing in growing season. The triptolide in phloem is less affected by the season.
Chromatography, High Pressure Liquid ; Diterpenes ; analysis ; metabolism ; Ecosystem ; Epoxy Compounds ; analysis ; metabolism ; Phenanthrenes ; analysis ; metabolism ; Plant Roots ; anatomy & histology ; chemistry ; Plants, Medicinal ; anatomy & histology ; chemistry ; growth & development ; Seasons ; Species Specificity ; Time Factors ; Tripterygium ; anatomy & histology ; chemistry ; growth & development ; Xylem ; chemistry
9.Anticonvulsant effect of phencynonate hydrochloride on maximal electroshock seizure and the metrazol seizure threshold test in mice.
Yong-An WANG ; Wen-Xia ZHOU ; Yan-Qin LIU ; Jian-Quan ZHENG ; Ke-Liang LIU ; Jin-Xiu RUAN
Acta Pharmaceutica Sinica 2005;40(6):501-506
AIMTo test the antiepileptic effect of phencynonate hydrochloride and investigate its antiepileptic mechanism.
METHODSThrough establishment of different epilepsy models, antiepileptic effects of phencynonate hydrochloride and other drugs were examined. Besides, the effect of phencynonate hydrochloride and other compounds against NMDA-induced lethality in mice, NMDA-induced injury in rat primary hippocampal neuronal cultures and NMDA-induced current were also observed.
RESULTSPhencynonate hydrochloride produced a significant anticonvulsant effect on different epilepsy models. Furthermore, phencynonate hydrochloride also exerted its obvious protection against the lethal effects of NMDA in mice, antagonized the NMDA-induced injury in rat primary hippocampal neuronal cultures and blocked NMDA-induced current in a dose-dependent manner.
CONCLUSIONPhencynonate hydrochloride had a notable anticonvulsant effect on typical epilepsy models, its antiepileptic mechanism might relate to its antagonism against NMDA receptor.
Animals ; Animals, Newborn ; Anticonvulsants ; pharmacology ; therapeutic use ; Aza Compounds ; pharmacology ; therapeutic use ; Cells, Cultured ; Electroshock ; Female ; Glycolates ; pharmacology ; therapeutic use ; Hippocampus ; cytology ; Lethal Dose 50 ; Male ; Mice ; N-Methylaspartate ; toxicity ; Neurons ; drug effects ; Neuroprotective Agents ; pharmacology ; Pentylenetetrazole ; Rats ; Rats, Wistar ; Seizures ; chemically induced ; drug therapy
10.Screening of traditional Chinese remedies for SARS treatment.
Zhi-min WANG ; Xiao-xin ZHU ; Xiao-lan CUI ; Ai-hua LIANG ; Guan-hua DU ; Jin-xiu RUAN ; Jian-ning SUN ; Peng-tao LI ; Shuo-ren WANG
China Journal of Chinese Materia Medica 2003;28(6):484-487
The SARS epidemic is breaking out worldwide. To select suitable herbal drugs for clinical uses is important and urgent amongst the controversial treatment proposals. Nine pharmacological experimental models were used to evaluate the comprehensive efficacy of traditional Chinese remedies by cross validation in different institutes. Eight drugs were optimized for controlling different symptoms of SARS.
Animals
;
Drug Evaluation, Preclinical
;
Drugs, Chinese Herbal
;
isolation & purification
;
therapeutic use
;
Humans
;
Multiple Organ Failure
;
prevention & control
;
Phytotherapy
;
Plants, Medicinal
;
chemistry
;
Severe Acute Respiratory Syndrome
;
drug therapy
Result Analysis
Print
Save
E-mail